Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 1;51(40):10185-9.
doi: 10.1002/anie.201205601. Epub 2012 Sep 7.

Chemical synthesis of a heparan sulfate glycopeptide: syndecan-1

Affiliations

Chemical synthesis of a heparan sulfate glycopeptide: syndecan-1

Bo Yang et al. Angew Chem Int Ed Engl. .

Abstract

The highly complex structure of syndecan-1 heparan sulfate glycopeptide was successfully assembled. The protective groups utilized and sequences for glycosyl linkage formation and protective group removal are critical for the success of synthesis. This is the first time this type of sulfated glycopeptides has been prepared, which lays the foundation to access other members of this important class of molecules.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Retrosynthetic analysis of octasaccharide amino ester 6.
Scheme 1
Scheme 1
Reagents and conditions: a) AgOTf, p-TolSCl, MS 4Å, −78°C, then 11, TTBP, −78°C–0°C; b) (1) Mg(OMe)2, DCM, −20°C–0°C; (2) LevOH, EDC-HCl, DMAP, DCM; (3) DDQ, DCM/H2O; (4) HF/Pyridine; (5) TBDPSCl, imidazole, DCM; c) AgOTf, p-TolSCl, MS 4Å, −78°C, then 13, TTBP, −78°C–0°C; d) AgOTf, p-TolSCl, MS 4Å, −78°C, then 16, TTBP, −78°C–0°C; e) (1) DDQ, DCM/H2O; (2) HF/Pyridine; (3) TBDPSCl, imidazole, DCM.
Scheme 2
Scheme 2
Reagents and conditions: a) (1) AgOTf, p-TolSCl, MS 4Å, −78°C, then 19, TTBP, −78°C–0°C; (2) Tf2O, THF, H2O; b) AgOTf, p-TolSCl, MS 4Å, −78°C, then 5, TTBP, −78°C–0°C; c) (1) AcOH, NH2NH2, DCM/MeOH; (2) 22, AgOTf, p-TolSCl, MS 4Å, TTBP, −78°C–0°C; d) AgOTf, p-TolSCl, MS 4Å, −78°C, then 23, TTBP, −78°C–0°C; e) AgOTf, p-TolSCl, MS 4Å, −78°C, then 5, TTBP, −78°C–0°C; f) AcOH, NH2NH2, DCM/MeOH.
Scheme 3
Scheme 3
Reagents and conditions: a) AgOTf, p-TolSCl, MS 4Å, −78°C, then 8, TTBP, −78°C–0°C; b) AgOTf, p-TolSCl, MS 4Å, −78°C, then 9, TTBP, −78°C–0°C; c) (1) HF/pyridine; (2) TEMPO, BAIB, DCM/H2O/t-BuOH; (3) MeI, K2CO3, DMF.
Scheme 4
Scheme 4
Reagents and conditions: a) (1) Ac2O, pyridine, 50 °C; (2) piperidine, DCM; b) HATU, DIPEA, DMF; c) Pd/C, H2, NH4OAc, DCM/MeOH; d) multiple rounds of automated solid phase peptide synthesis; e) TFA/H2O/Phenol/TIPS; f) (1) BnBr, DIPEA, DMF; (2) piperidine, DMF; g) HATU, DMF; h) (1) Zn, CuSO4 (sat.), Ac2O/THF/HOAc; (2) NH2NH2-H2O, HOAc, DCM/MeOH; (3) SO3-Et3N, DMF, 55 °C; (4) H2, Pd/C, DCM/MeOH; i) base catalyzed hydrolysis

References

    1. Bernfield M, Götte M, Park PW, Reizes O, Fitzgerald ML, Lincecum J, Zako M. Annu Rev Biochem. 1999;68:729–777. - PubMed
    1. Tumova S, Woods A, Couchman JR. Int J Biochem Cell Biol. 2000;32:269–288. - PubMed
    1. Choi Y, Chung H, Jung H, Couchman JR, Oh ES. Matrix Biol. 2011;30:93–99. - PubMed
    2. Lambaerts K, Wilcox-Adelman SA, Zimmermann P. Curr Opin Cell Biol. 2009;21:662–669. - PMC - PubMed
    3. Khotskaya YB, Dai Y, Ritchie JP, MacLeod V, Yang Y, Zinn K, Sanderson RD. J Biol Chem. 2009;284:26085–26095. - PMC - PubMed
    4. Bass MD, Morgan MR, Humphries MJ. Sci Signal. 2009;2:pe18. - PMC - PubMed
    5. Lin X. Development. 2004;131:6009–6021. - PubMed
    1. Yang Y, MacLeod V, Dai Y, Khotskaya-Sample Y, Shriver Z, Venkataraman G, Sasisekharan R, Naggi A, Torri G, Casu B, Vlodavsky I, Suva LJ, Epstein J, Yaccoby S, Shaughnessy JD, Barlogie B, Sanderson RD. Blood. 2007;110:2041–2048. - PMC - PubMed
    1. De Cat B, Muyldermans SY, Coomans C, Degeest G, Vanderschueren B, Creemers J, Biemar F, Peers B, David G. J Cell Biol. 2003;163:625–635. - PMC - PubMed
    2. Iozzo RV. J Clin Invest. 2001;108:165–167. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources